Skip to Main Content

Paper Details

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.
J Clin Oncol
36
2022
342 AAP, AAP, Abiraterone, Docetaxel, Men, Patient, Patients, Prostate Cancer, QLQ, abiraterone acetate, androgen, docetaxel, fatigue, hormone-sensitive prostate cancer, metastatic, patient, patients, prednisolone, prednisone
Author NameAffiliation
Gerhardt AttardUCL Cancer Institute
Emma GrayMusgrove Park Hospital
Peter HoskinUniversity of Manchester
Peter HoskinMount Vernon Cancer Centre and University of Manchester
  • 1 - 4

Datasets

Release 1.2